Cite

    Toshitsugu Sugimoto et al.. “A randomized, double-blind, placebo-controlled study of once weekly elcatonin in primary postmenopausal osteoporosis.” Current medical research and opinion, vol. 35, 2019, pp. 447–454. http://access.bl.uk/ark:/81055/vdc_100077435697.0x000042